chrisvoncsefalvay/vaers-outcomes huggingface dataset:
SWEATY; CHILLS; FEVERISH; REALLY TIRED; This spontaneous report received from a consumer concerned a 51 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022, expiry: UNKNOWN) dose was not reported, administered on 08-MAR-2021 13:00 for prophylactic vaccination. No concomitant medications were reported.  On 08-MAR-2021 19:00, the subject experienced chills. On 08-MAR-2021 19:00, the subject experienced feverish. On 08-MAR-2021 19:00, the subject experienced really tired. On 09-MAR-2021 05:00, the subject experienced sweaty. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sweaty, chills, feverish, and really tired on 09-MAR-2021 18:30. This report was non-serious. This case, from the same reporter is linked to.
Extreme pain in right leg for 2 days. Went to ER and had ultrasound to rule out blood clot. Went to primary doctor's office and was treated for Baker's cysts behind the knee. Have an aquaintaince in state that had the same reaction.  Shot was administered at the  convention  center.  Prescribed:  Hydrocodone, Methylprednisolone, & Baclofen.
Patient presented with pain and swelling on left arm, fever, headache and nausea. Treated with MOTRIN and cold compress at home.
soreness of arm after 1st dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 10Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Mar2021, outcome "unknown", described as "soreness of arm after 1st dose".  Additional information: Patient experienced soreness of arm after 1st dose (10Mar2021) and now he's asked if he can take Tylenol or Advil after his 2nd dose which was dated on 31Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
4/4/08 Office visit stating she has hard, sore lump on left arm - no bruising or redness noted.  4/8/08 OV stating arm throbbing from elbow to hand.  4/9/08 OV bruise larger than half dollar at injection site connected by thin bruise line to another bruised area below and left of initial site.
CANCER; This spontaneous report received from a consumer via a company representative via social media concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin was not reported, batch number: Unknown, expiry: Unknown) dose was not reported, 1 total, administered on an unspecified date for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced cancer. The reporter stated that " my boyfriend and best friend, both developed 2 different cancers after receiving the shot. Weird, Coincidence or is the shot what some say it is, It sure was not tested long after it was made". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of cancer was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20221143605.; Sender's Comments: V0: 20221146108- Cancer. The event has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event. Therefore, the WHO Causality is considered indeterminate. The company causality is considered unassessable.
Itching, not severe, which is ongoing. No rash or hives.Temporary numbness on right side of face. Temporary tingling on face.
My L arm became sore about 2 hrs after injection. An area, about 2" below injection site, became red and sore.....this was about 2" long and 1" wide. At about 2am that night I awoke with chills, body aches, joint aches....even my skin hurt! It felt like a really bad case of the flu. Able to sleep off and on....lo grade temp in the morning. Exhausted, no appetite and slept a good part of the day on Thursday. Felt pretty much back to normal by Friday, March 8th. Took TYLENOL x2.
Terrible diarrhea; Weakness in legs where "I" could not stand up; Chills; Broke out in a cold sweat; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the right arm on 19Apr2021 at 17:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes, high blood pressure, high cholesterol, depression, anxiety, hypothyroidism, penicillin allergy and allergy to all fruits and fruit pectin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included dulaglutide (TRULICITY) and lisinopril (MANUFACTURER UNKNOWN); both for unknown indication from an unknown start date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 22Mar2021 at 17:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. On 19Apr2021 at 20:45 (also reported as 21:00), approximately 3 hours after the vaccination, the patient experienced terrible diarrhea, weakness in the legs where the patient could not stand up, broke out in a cold sweat and also had chills. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event terrible diarrhea, weakness in the legs where the patient could not stand up, broke out in a cold sweat and chills was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Tightness in stomach; loss of appetite; This is a spontaneous report received from a non-contactable reporter (Consumer or other non HCP). The reporter is the patient.  A male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ABDOMINAL PAIN UPPER (non-serious), outcome "not recovered", described as "Tightness in stomach"; DECREASED APPETITE (non-serious), outcome "not recovered", described as "loss of appetite".  Additional information: The patient received the first shot of the vaccine 3 to 4 weeks ago. The patient was asking how long the side effects are supposed to last and if he takes medication will that have an adverse effect on ways the vaccine works and vice versa.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Hives all over body; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 16Mar2021 at 16:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included type 1 diabetes mellitus, hashimoto's disease and eosinophilic esophagitis. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9809) via an unspecified route of administration in the left arm on 23Feb2021 at 16:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Concomitant medications included insulin aspart (NOVOLOG), levothyroxine sodium (LEVOXYL), simvastatin (MANUFACTURER UNKNOWN) and enalapril (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Mar2021 at 17:00, the patient experienced hives all over body. Its reported that after the second shot patient had 1 hive at 17:00, hives all over body at 01:30. It had been 4 weeks and still breakout in hives if do not take zyrtec. Therapeutic measures were taken as a result of the adverse event and included treatment with zyrtec. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event of hives all over body was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Same day/evening, slight headache on left side; runny nose; tiredness; right arm strong discomfort; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 61 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 24Mar2021 15:45 (Lot number: EP6955) at the age of 61 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose: 1, Arm left, 11:45 AM), administration date: 03Mar2021, for Covid 19 immunization. The following information was reported: HEADACHE (non-serious) with onset 24Mar2021 18:00, outcome "recovered", described as "Same day/evening, slight headache on left side"; RHINORRHOEA (non-serious) with onset 24Mar2021 18:00, outcome "recovered", described as "runny nose"; FATIGUE (non-serious) with onset 24Mar2021 18:00, outcome "recovered", described as "tiredness"; LIMB DISCOMFORT (non-serious) with onset 24Mar2021 18:00, outcome "recovered", described as "right arm strong discomfort". Therapeutic measures were not taken as a result of headache, rhinorrhoea, fatigue, limb discomfort. Additional information: The facility where the most recent COVID-19 vaccine was administered in other (as reported). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. Patient had no allergies to medications, food, or other products.  No follow-up attempts are possible. No further information is expected.
NUMBNESS IN TONGUE; TINGLING IN TONGUE; MIGRAINE HEADACHE; SENSES WERE ALL HYPERSENSITIVE/ SENSE OF SMELL; This spontaneous report received from a patient concerned a 66 year old of unspecified sex. The patient's height, and weight were not reported. The patient's past medical history included migraine. The patient was previously treated with acetylsalicylic acid/caffeine/paracetamol/salicylamide for migraine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041H21A/041A21A/041H21H expiry: UNKNOWN) dose was not reported, administered on 02-APR-2021 for prophylactic vaccination. Concomitant medications included estradiol, levothyroxine sodium, progesterone, and testosterone. On 09-APR-2021, the subject experienced numbness in tongue. On 09-APR-2021, the subject experienced tingling in tongue. On 09-APR-2021, the subject experienced migraine headache. On 09-APR-2021, the subject experienced senses were all hypersensitive/ sense of smell. Treatment medications (dates unspecified) included: acetylsalicylic acid/caffeine/paracetamol/salicylamide. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from migraine headache, and the outcome of numbness in tongue, tingling in tongue and senses were all hypersensitive/ sense of smell was not reported. This report was non-serious.
Since my J&J vaccine, I have limited mobility on my left shoulder, at the injection site, still sore and can not lift my left arm to full extent.
injection site red  swollen and hot to touch  approx. 4 x 4 inches .  patient c/o it was "itchy"  but no other complaints
On 07/05/2022 I noticed my throat felt a little funny like I was getting a little cold, runny nose. I took a home test which showed positive.  I seen my doctor on Thursday and had a rapid test done in the office which also showed positive. I was not given any prescriptions just used over the counter medication. As of today I am not having any symptoms.
hives all over the body w/swelling of palms & feet 1 day p/vax;
Information has been received from a registered nurse concerning a 10 year old female who on 04-FEB-1997 was vaccinated SQ with 0.5 mL VARIVAX (Oka/Merck) when she was 12 months old. Concomitant therapy included ZITHROMAX. Subsequently the patient developed a mild case of chickenpox at age 10 years, in approximately 2006. No lab diagnostic studies were performed. The patient's outcome was not reported. Additional information has been requested.
Sunday October 31 difficulty pronouncing words, suspected TIA that resolved shortly later. Sunday November 14 sudden onset of heart palpitations
This spontaneous report was received from a licensed practitioner nurse referring to a 1 day-old child of unknown gender. There was no pertinent medical history, concomitant medication or drug allergies/drug reactions described. The reporter stated that on 28-JUL-2015, the patient was administered an improperly stored dose of LIQUID PEDVAXHIB injection (lot # K026533, with expiration date: 07-AUG-2017; dose, frequency and route were not reported). No adverse effects were reported. It was unknown if the patient sought medical attention. Product quality complaint (PQC) was not involved. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous report was received from a registered nurse referring to a patient of unknown age. The patient's current condition, pertinent medical history and concomitant therapy were not reported. On 25-OCT-2021, the patient had inadvertent concomitant administration of measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD) (lot # T037955 and expiration date reported as 09-MAY-2022), 0.5 ml and varicella virus vaccine live (oka/merck)(VARIVAX) (Lot # T035400 and expiration date reported as 16-Oct-2022), 0.5 ml for prophylaxis (accidental overdose). No additional adverse events reported. No product quality complaints reported.
Extreme burning on left side chest and breast it became very enlarged , burning continued left side clavicle. Then burning redness rash move right side Che?s not as severe as left , left side of chest began peeling.
pt recv vax 12MAY98 & 15MAY98 pt devel an intense drawing sensation in fingers of both hands w/numbness & pain;
Since getting the vaccine continuous arms/legs falling asleep/numb/pins and needles/feeling like sharp pricks and irritation
The needle was positioned too high on my shoulder, causing extreme pain in the following 2 weeks. It?s been almost 2 months later now and I still have lingering pain in my shoulder with movement and restriction of my range of motion. It limits my capacity at my job as well as a bedside nurse, I have trouble lifting patients and performing patient care.
Dose prepared on 7/2/2021 and administered on 7/6/2021.  Patient did not report any adverse symptoms.
Severe muscle spasms from hips down.  One year later -still experiencing tingling and achiness.   Past 2 weeks the symptoms have gotten worse.
arm pain; Felt sick; felt like the getting the flu; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain), MALAISE (Felt sick), INFLUENZA LIKE ILLNESS (felt like the getting the flu), PYREXIA (fever) and CHILLS (chills) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037A21B and 001B21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (allergic to epinephrine), Thyroid disorder (thyroid condition) and Mitral valve prolapse (heart condition).   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm pain), MALAISE (Felt sick), INFLUENZA LIKE ILLNESS (felt like the getting the flu), PYREXIA (fever) and CHILLS (chills). At the time of the report, PAIN IN EXTREMITY (arm pain), MALAISE (Felt sick), INFLUENZA LIKE ILLNESS (felt like the getting the flu), PYREXIA (fever) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Protein total: 1.78 or 1.76 level of 1.78 or 1.76 after 8.5 months from the second dose.         No concomitant medications were reported. No treatment medications were reported. Patient stated that they have not been working because they were hurt but clarified that was regarding something that has been going on for years. Patient had arm pain, felt sick, had fever and chills and felt like the getting the flu for a couple of days.   This case was linked to MOD-2021-428505 (Patient Link).
sharp pain running up her neck to her head/./she could not stand the pain; her left arm swelled up; left arm was still red and irritated; sharp pain running up her neck to her head; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NECK PAIN (sharp pain running up her neck to her head/./she could not stand the pain), VACCINATION SITE SWELLING (her left arm swelled up), VACCINATION SITE ERYTHEMA (left arm was still red and irritated) and HEADACHE (sharp pain running up her neck to her head) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 027A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced NECK PAIN (sharp pain running up her neck to her head/./she could not stand the pain). 18-Mar-2021, the patient experienced VACCINATION SITE SWELLING (her left arm swelled up), VACCINATION SITE ERYTHEMA (left arm was still red and irritated) and HEADACHE (sharp pain running up her neck to her head). At the time of the report, NECK PAIN (sharp pain running up her neck to her head/./she could not stand the pain), VACCINATION SITE SWELLING (her left arm swelled up), VACCINATION SITE ERYTHEMA (left arm was still red and irritated) and HEADACHE (sharp pain running up her neck to her head) outcome was unknown.            No concomitant medication information was provided. HCP advised she put ice packs on it. Treatment drug included Steroid shot and it worked well. Action taken with mRNA-1273 in response to the drug was not applicable.
High fever up to 104.6, moaning, swelling at injection site, vomiting (sx 12 hours). Baby did also have fever up to 102 after 4 month shots but no other symptoms.
Diffuse erythema /w tenderness & induration @ inject site of Td booster one day /p vax. RX:warm compress, APAP.
This spontaneous report as received from a registered nurse refers to a 12 months old male patient. The patient was inadvertently vaccinated with a 0.65 ml dose of ZOSTAVAX (lot# 0562AE, exp 20-MAR-2013) subcutaneously on left thigh instead of VARIVAX (Merck), due to staff error on 13-AUG-2012. No adverse effects was reported. It was unknown if the patient sought medical attention. Additional information is not expected.
NP called 10/30 to report patient had received flu shot in the joint space. Pt complained at visit that they would never have a flu shot again and how much it hurt. Told tech gave him his shot and there was a lot of chaos in the RxCu. Pt was injected twice after hitting bone. There is swelling/bulging. He is seeing a shoulder specialist (another problem exists). Will ask their opinion.
Received Varivax on 7/13/09 on 7/14 at injection site a mild erythemia appeared as approximately 4cm circle.   no treatment needed
6/20/05 Monday some dizziness, 6/21/05 wheezing chest tight progressed to fever T 100.6 progressed to GI s/s stomach cramps, everything hurt, diarrhea, anorexia, fever 101-102 lasting 1 week, dehydration. MD on 6/24/05 urgent care, diarrhea continued, to 6/28/05. Now better.
Fever. headache, muscle ache, fatigue, generalized abdominal pain - all symptoms began 1 hour after receiving MC4 vaccination.
first day of vaccine, developed a runny nose (Wednesday, Jan 6) second day, felt fatigued third day, felt lungs were burning and chest heaviness, tachycardia ~ 90's (today) went to an urgent care at work place tonight, lungs clear
A nurse reported that a 15 month old female received her 1st injection of Prevnar and Fluzone vaccines on 12/4/00. Later that day, the child developed an injection site reaction characterized by bruising and pain upon touching. Two days later, the child experienced viral syndrome with diarrhea and a fever of 102.5F. This report is 1 of 3 cases of injection site reactions secondary to the same lot of Prevnar reported from the same institution. See case ID #'s HQ4692111DEC2000 and HQ6902606FEB2001 for the reports on the other cases. Follow-up information received on 3/5/01 revealed the child was not receiving concomitant medications.
Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Chest Tightness / Heaviness / Pain-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Additional Details: passed out momentarily, confuzed when regained consciousness, complained of chest pain with breathing